The Cutting Edge of Medical Technology Content, Community & Collaboration
U.S. AHRQ Announces $29million "Stimulus" Funding for (R18) Comparative Effectiveness Research (CER)
Colleagues,
This is the second of two separate announcements on "Stimulus' funded Comparative Effectiveness Research (CER) ...
... The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) announced RFA-HS-10-004, Innovative Adaption and Dissemination of AHRQ Comparative Effectiveness Research Products (iADAPT) (R18) supported by $29.5 million in funds provided under the American Recovery and Reinvestment Act of 2009, i.e., "Stimulus" funding...
... The FOA invites grant applications for new projects to extend the reach and impact of Comparative Effectiveness Research Reviews and associated products, particularly Comparative Effectiveness Research Summary Guides, which are prepared by the John M. Eisenberg Clinical Decisions and Communications Science Center, part of the AHRQ Effective Health Care Program ...
... Adaptations should aim to increase the impact and effective use of one or more comparative effectiveness research products by developing, implementing, and evaluating product adaptations that target three important audiences: stakeholders, systems, and settings. The adaptations may involve customizing the original comparative effectiveness research contents to a specialized clinical audience of potential users or translating the Comparative Effectiveness Research Summary Guides for underserved patient and consumer populations who have limited access to medication information on the Internet...
... AHRQ anticipates making 20 to 25 awards that together total $29.5 million ... Applications may be up to 3 years in duration, with a total budget not to exceed $1.5 million over the 3 years. While total annual costs may vary over the period of the award, the maximum cost in any one year cannot exceed $1 million.
Sample Interest Areas ... include, but are not limited to, the following:
* Adaptation of the content and/or delivery mechanism of CER Review Products or CERSGs to improve their penetration and use at the policy, health systems, clinical practice, caregiver, and patient levels.
* Development/refinement demonstration, and evaluation of processes or products to incorporate CER evidence (as captured in CER Review Products, including CER Reviews, CER Executive Summaries, and CERSGs) into decision-making settings or processes for patients/consumers, clinicians, and policymakers.
* Strategies to test, via demonstration(s), the role and impact on behavior of informatics in the dissemination and application of CER evidence from CER Review Products, including CERSGs, to patients/consumers, clinicians, and policymakers.
* General public awareness campaign(s) to identify the value and contributions of CERSGs and related comparative effectiveness research products to high quality health care and shared decision-making between patients and their clinicians.
* Innovative behavioral and social sciences or information technology research to determine the best methods in patient/provider communication and decisional support, including the use and consequences of alternative information technologies for displaying or disseminating CER information such as that available in CERSGs.
* Locally-sensitive adaptation and dissemination of CERSGs (with supplemental information from CER Review Executive Summaries as deemed necessary and pertinent) that take into consideration one or more defined audiences or stakeholder groups (such as the elderly, disabled, rural, poor, rachial and ethnic minority, educationally or literacy disadvantaged, and others), whose specialized needs, communication channels, social infrastructure, or other resources can facilitate reaching them with relevant and valuable comparative effectiveness information.
* Identification and characterization of stakeholder groups where CER Review Products, especially CERSGs, have limited or no penetration with the purpose to obtain critical feedback on how to improve CERSG translation and dissemination for their use.
Targeted Stakeholder/Community Groups/Settings
... AHRQ seeks applications that target diverse groups, address unmet needs, offer generalizable lessons, and afford the greatest possible public health impact in terms of disease burden and the quality, safety, effectiveness, and efficiency of health care...
... Groups and/or settings for adaptation or dissemination of CER Review Products or CERSGs may be conceptualized by geography, urban/rural/MSA residence, demographics, organizational unit(s), social or other networks, or other schema. Examples include faith-based communities, regional health information organizations, hospital chains, policymakers including governments and health departments at the state, regional, county, or Federal level, and clinicians and other providers who serve underserved populations or those with special needs. Other candidates include, but are not limited to, advocacy organizations, senior citizen centers, community health centers, or Federally- funded health centers. AHRQ welcomes and encourages applications that address the needs of priority populations, particularly groups that are underserved and difficult to reach through traditional methods...
... A wide range of mechanisms, media, and communication channels may be considered, including but not limited to:
* paper-based products, such as brochures, narratives, or case studies that are adapted in design, format, or language to colloquial usage or cultural sensitivities
* electronic or technology-based dissemination channels or tools, such as internet, TV, radio, cell phone, social networking sites, listservs, health avatars, and others
* adaptation to electronic health records, personal health records, electronic medical records, or clinical decision support aids attached to these systems
* Personal interactions occurring through one-on-one interactions (such as academic detailing, kitchen table meetings) or group discussions (such as focus groups, social or health care professional meetings, town hall meetings), or routine settings such as work, school, or health care clinics.
... Letters of Intent Receipt Date(s): November 18, 2009
... Applications are due on December 16, 2009.
Read on at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-004.html
ENJOY!
CC
This is the second of two separate announcements on "Stimulus' funded Comparative Effectiveness Research (CER) ...
... The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) announced RFA-HS-10-004, Innovative Adaption and Dissemination of AHRQ Comparative Effectiveness Research Products (iADAPT) (R18) supported by $29.5 million in funds provided under the American Recovery and Reinvestment Act of 2009, i.e., "Stimulus" funding...
... The FOA invites grant applications for new projects to extend the reach and impact of Comparative Effectiveness Research Reviews and associated products, particularly Comparative Effectiveness Research Summary Guides, which are prepared by the John M. Eisenberg Clinical Decisions and Communications Science Center, part of the AHRQ Effective Health Care Program ...
... Adaptations should aim to increase the impact and effective use of one or more comparative effectiveness research products by developing, implementing, and evaluating product adaptations that target three important audiences: stakeholders, systems, and settings. The adaptations may involve customizing the original comparative effectiveness research contents to a specialized clinical audience of potential users or translating the Comparative Effectiveness Research Summary Guides for underserved patient and consumer populations who have limited access to medication information on the Internet...
... AHRQ anticipates making 20 to 25 awards that together total $29.5 million ... Applications may be up to 3 years in duration, with a total budget not to exceed $1.5 million over the 3 years. While total annual costs may vary over the period of the award, the maximum cost in any one year cannot exceed $1 million.
Sample Interest Areas ... include, but are not limited to, the following:
* Adaptation of the content and/or delivery mechanism of CER Review Products or CERSGs to improve their penetration and use at the policy, health systems, clinical practice, caregiver, and patient levels.
* Development/refinement demonstration, and evaluation of processes or products to incorporate CER evidence (as captured in CER Review Products, including CER Reviews, CER Executive Summaries, and CERSGs) into decision-making settings or processes for patients/consumers, clinicians, and policymakers.
* Strategies to test, via demonstration(s), the role and impact on behavior of informatics in the dissemination and application of CER evidence from CER Review Products, including CERSGs, to patients/consumers, clinicians, and policymakers.
* General public awareness campaign(s) to identify the value and contributions of CERSGs and related comparative effectiveness research products to high quality health care and shared decision-making between patients and their clinicians.
* Innovative behavioral and social sciences or information technology research to determine the best methods in patient/provider communication and decisional support, including the use and consequences of alternative information technologies for displaying or disseminating CER information such as that available in CERSGs.
* Locally-sensitive adaptation and dissemination of CERSGs (with supplemental information from CER Review Executive Summaries as deemed necessary and pertinent) that take into consideration one or more defined audiences or stakeholder groups (such as the elderly, disabled, rural, poor, rachial and ethnic minority, educationally or literacy disadvantaged, and others), whose specialized needs, communication channels, social infrastructure, or other resources can facilitate reaching them with relevant and valuable comparative effectiveness information.
* Identification and characterization of stakeholder groups where CER Review Products, especially CERSGs, have limited or no penetration with the purpose to obtain critical feedback on how to improve CERSG translation and dissemination for their use.
Targeted Stakeholder/Community Groups/Settings
... AHRQ seeks applications that target diverse groups, address unmet needs, offer generalizable lessons, and afford the greatest possible public health impact in terms of disease burden and the quality, safety, effectiveness, and efficiency of health care...
... Groups and/or settings for adaptation or dissemination of CER Review Products or CERSGs may be conceptualized by geography, urban/rural/MSA residence, demographics, organizational unit(s), social or other networks, or other schema. Examples include faith-based communities, regional health information organizations, hospital chains, policymakers including governments and health departments at the state, regional, county, or Federal level, and clinicians and other providers who serve underserved populations or those with special needs. Other candidates include, but are not limited to, advocacy organizations, senior citizen centers, community health centers, or Federally- funded health centers. AHRQ welcomes and encourages applications that address the needs of priority populations, particularly groups that are underserved and difficult to reach through traditional methods...
... A wide range of mechanisms, media, and communication channels may be considered, including but not limited to:
* paper-based products, such as brochures, narratives, or case studies that are adapted in design, format, or language to colloquial usage or cultural sensitivities
* electronic or technology-based dissemination channels or tools, such as internet, TV, radio, cell phone, social networking sites, listservs, health avatars, and others
* adaptation to electronic health records, personal health records, electronic medical records, or clinical decision support aids attached to these systems
* Personal interactions occurring through one-on-one interactions (such as academic detailing, kitchen table meetings) or group discussions (such as focus groups, social or health care professional meetings, town hall meetings), or routine settings such as work, school, or health care clinics.
... Letters of Intent Receipt Date(s): November 18, 2009
... Applications are due on December 16, 2009.
Read on at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-004.html
ENJOY!
CC
Views: 3
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
